Search Results 871-880 of 17081 for monoclonal antibody

  1. Overview - Department of Immunology - Mayo Clinic Research

    Chronic inflammation; Infections; Tissue transplantation. Two institutional core research resources, the Antibody Hybridoma Core and the Immune Monitoring Core, ...

  2. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... monoclonal antibody * For Cohorts G, H, and I: Has symptomatic ascites or pleural effusion * For Cohort I: Has clinically active diverticulitis, intra ...

  3. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a ... monoclonal antibody with the exception of blinatumomab; patients must have ...

  4. Phase 1a/​1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers - Mayo Clinic

    * Treatment with a monoclonal antibody, or any other anticancer agent (including biologic, experimental, or hormonal therapy) investigational or otherwise ...

  5. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

    anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; an anthracycline containing chemotherapy regimen;; for subjects ...

  6. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Any prior treatment with CD38 targeting monoclonal antibodies, including daratumumab or isatuximab-irfc;; Administration of the Janssen COVID-19 vaccine ...

  7. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

    ... antibody, administered ... - History of or ongoing pulmonary fibrosis or interstitial lung disease. 10. Known severe hypersensitivity reactions to monoclonal ...

  8. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...

  9. A Study to Evaluate the Safety and Effectiveness of JBH492 in Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma - Mayo Clinic

    ... monoclonal antibody administration. Any prior history of treatment with maytansine (DM1 or DM4)-based ADC. Known intolerance to a maytansinoid. Patients ...

  10. Department of Immunology - Mayo Clinic Research

    Chronic inflammation; Infections; Tissue, organ and bone marrow transplantation. Departmental faculty also have oversight responsibilities for the Antibody ...